Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123270183 | 12327018 | 3 | F | 20130124 | 20160816 | 20160503 | 20160827 | EXP | CA-AMGEN-CANSP2013020048 | AMGEN | 51.00 | YR | A | M | Y | 0.00000 | 20160827 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123270183 | 12327018 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 123270183 | 12327018 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 25 MG, QWK | 0 | 25 | MG | /wk | |||||||
| 123270183 | 12327018 | 3 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 123270183 | 12327018 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 123270183 | 12327018 | 5 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | 0 | ||||||||||
| 123270183 | 12327018 | 6 | SS | NAPROSYN | NAPROXEN | 1 | Unknown | 500 MG, TWICE A DAY | 0 | 500 | MG | BID | |||||||
| 123270183 | 12327018 | 7 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 125 MG, QWK | 0 | 125 | MG | /wk | |||||||
| 123270183 | 12327018 | 8 | SS | APO-METHOTREXATE | METHOTREXATE | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 123270183 | 12327018 | 9 | SS | ABATACEPT | ABATACEPT | 1 | Subcutaneous | 125 MG, UNK | 0 | 125 | MG | ||||||||
| 123270183 | 12327018 | 10 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 20 MG, A DAY | 0 | 20 | MG | ||||||||
| 123270183 | 12327018 | 11 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 2.5 MG, QWK | 0 | 2.5 | MG | /wk | |||||||
| 123270183 | 12327018 | 12 | C | NAPRELAN | NAPROXEN SODIUM | 1 | 1000 MG, QD | 0 | 1000 | MG | QD | ||||||||
| 123270183 | 12327018 | 13 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, 4 TIMES/WK | 0 | 5 | MG | |||||||||
| 123270183 | 12327018 | 14 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 123270183 | 12327018 | 15 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 16 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 123270183 | 12327018 | 17 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 18 | C | LOVASTATIN. | LOVASTATIN | 1 | UNK | 0 | TABLET | ||||||||||
| 123270183 | 12327018 | 19 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 20 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 21 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 22 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 123270183 | 12327018 | 23 | C | NAPROXEN. | NAPROXEN | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 24 | C | NAPROXEN SODIUM. | NAPROXEN SODIUM | 1 | UNK | 0 | |||||||||||
| 123270183 | 12327018 | 25 | C | ROSUVASTATIN CALCIUM. | ROSUVASTATIN CALCIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123270183 | 12327018 | 1 | Rheumatoid arthritis |
| 123270183 | 12327018 | 2 | Rheumatoid arthritis |
| 123270183 | 12327018 | 3 | Rheumatoid arthritis |
| 123270183 | 12327018 | 4 | Rheumatoid arthritis |
| 123270183 | 12327018 | 5 | Rheumatoid arthritis |
| 123270183 | 12327018 | 6 | Rheumatoid arthritis |
| 123270183 | 12327018 | 7 | Rheumatoid arthritis |
| 123270183 | 12327018 | 8 | Product used for unknown indication |
| 123270183 | 12327018 | 9 | Product used for unknown indication |
| 123270183 | 12327018 | 10 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123270183 | 12327018 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123270183 | 12327018 | Activities of daily living impaired | |
| 123270183 | 12327018 | Adverse reaction | |
| 123270183 | 12327018 | Anaemia | |
| 123270183 | 12327018 | Arthralgia | |
| 123270183 | 12327018 | Back disorder | |
| 123270183 | 12327018 | Blood albumin decreased | |
| 123270183 | 12327018 | C-reactive protein increased | |
| 123270183 | 12327018 | Diverticular perforation | |
| 123270183 | 12327018 | Diverticulum | |
| 123270183 | 12327018 | Drug ineffective | |
| 123270183 | 12327018 | Drug intolerance | |
| 123270183 | 12327018 | Hand deformity | |
| 123270183 | 12327018 | Headache | |
| 123270183 | 12327018 | Joint range of motion decreased | |
| 123270183 | 12327018 | Joint stiffness | |
| 123270183 | 12327018 | Joint swelling | |
| 123270183 | 12327018 | Lymphadenopathy | |
| 123270183 | 12327018 | Musculoskeletal stiffness | |
| 123270183 | 12327018 | Neck mass | |
| 123270183 | 12327018 | Pain | |
| 123270183 | 12327018 | Pain in extremity | |
| 123270183 | 12327018 | Peripheral swelling | |
| 123270183 | 12327018 | Rheumatoid arthritis | |
| 123270183 | 12327018 | Spinal operation | |
| 123270183 | 12327018 | Surgery | |
| 123270183 | 12327018 | Thrombocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123270183 | 12327018 | 1 | 20130124 | 0 | ||
| 123270183 | 12327018 | 22 | 20150704 | 0 |